Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Radiology benefit management programs can protect patients from radiation exposure

Making sure patients receive the right diagnostic imaging tests at the right times in high-quality facilities significantly reduces unnecessary radiation exposure, HealthHelp chief medical officer Mark Hiatt, M.D., testified at a public meeting held by the U.S. Food and Drug Administration.

1 Apr 2010

PolyMedix secures $14M credit facility with Hercules Technology II

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has secured a $14 million credit facility with Hercules Technology II, L.P., an affiliate of Hercules Technology Growth Capital, Inc.

1 Apr 2010

Biostar Pharmaceuticals fiscal 2009 revenues up 57.2%

Biostar Pharmaceuticals, Inc., the Xianyang-based manufacturer of a leading over-the-counter Hepatitis B medicine, Xin Aoxing Oleanolic Acid Capsule, and other pharmaceutical products, today announced its 2009 year-end financial results.

1 Apr 2010

Soligenix's revenues for 2009 increase by 22%

Soligenix, Inc., a late-stage biopharmaceutical company, today announced its financial results for 2009.

1 Apr 2010

Tanda Professional Restore light therapy now made available for at-home use

During a press conference yesterday, doctors and experts unveiled a groundbreaking medical device using the healing properties of light therapy for pain management and improving mobility. For the first time ever, a licensed medical device that delivers clinical levels of light therapy only previously available in a doctor's office, has now been made available for at-home use.

1 Apr 2010

Cord Blood America signs License and Cooperation Agreement with AXM Pharma in China

Cord Blood America, Inc., the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, announced today that it has signed a License and Cooperation Agreement for the processing and storage of umbilical cord blood in China with AXM Pharma, Inc.

1 Apr 2010

IVAX Diagnostics reports net revenue of $4.5M for quarter ended December 31, 2009

IVAX Diagnostics, Inc., a fully integrated in vitro diagnostics company, reports its financial results for the fourth quarter and full year ended December 31, 2009.

31 Mar 2010

2010 BIO International Convention to discuss issues that impact drug discovery and development

The 2010 BIO International Convention will feature a robust health and medical program highlighting the latest scientific breakthroughs and policy and business development issues that impact drug discovery and development. Hosted by the Biotechnology Industry Organization, the Convention will be held May 3-6, 2010 in Chicago, Ill. at McCormick Place.

31 Mar 2010

Tongjitang Chinese Medicines' net revenue rises 31.5% in fourth quarter 2009

Tongjitang Chinese Medicines Company, a leading specialty pharmaceutical company focusing on the development, manufacturing, marketing and selling of modernized traditional Chinese medicine in China, today announced its financial results for the fourth quarter of 2009 and for the full year ended December 31, 2009.

31 Mar 2010

Sanofi Pasteur accelerates deployment of Intercim's Pertinence Suite MOM software solution

Intercim, announces that Sanofi Pasteur, the vaccines division of the Sanofi-aventis Group, is accelerating the use of Pertinence Suite, Manufacturing Operations Management (MOM) software solution, within the European and North American sites of the worldwide leader of vaccines.

31 Mar 2010

AgaMatrix, sanofi-aventis announce long-term partnership for BGM solutions

AgaMatrix, Inc. and sanofi-aventis today announced that they have signed a long-term agreement for the development, supply and commercialization of blood glucose monitoring (BGM) solutions. Under the terms of the agreement, AgaMatrix and sanofi-aventis will co-develop innovative solutions in diabetes management that incorporate AgaMatrix's WaveSense™ technology. Sanofi-aventis will commercialize through its Global Diabetes Division such integrated solutions for patients with diabetes, along with current sanofi-aventis insulins and delivery devices.

31 Mar 2010

Ikaria Holdings acquires NDA and IND application for LUCASSIN drug

Ikaria Holdings, Inc. announced today that it has acquired the New Drug Application (NDA) and the Investigational New Drug (IND) application to LUCASSIN® (terlipressin for injection) from Orphan Therapeutics, assuming all future development and ownership of the drug in North America and Australia.

31 Mar 2010

Hospira acquires Orchid's injectables formulations business

Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has completed the acquisition of the generic injectable pharmaceuticals business of Orchid Chemicals & Pharmaceuticals Ltd., a leading Indian pharmaceuticals company, for approximately $400 million.

31 Mar 2010

Savient Pharmaceuticals' resubmission of BLA for KRYSTEXXA accepted for FDA review

Savient Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has acknowledged receipt of and accepted for review the March 15, 2010 resubmission of the Biologics License Application for KRYSTEXXA™ (pegloticase), a treatment for chronic gout in patients refractory to conventional therapy.

30 Mar 2010

Campbell Soup honored for commitment to food allergy safety, awareness and education

Campbell Soup Company was recently honored by the Food Allergy and Anaphylaxis Network for its commitment to food allergy safety, awareness and education.

30 Mar 2010

Investment report on Fonar from InvestorSoup.com

InvestorSoup.com announces an investment report featuring Fonar Corp. The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.

30 Mar 2010

Kun Run Biotechnology's fiscal 2009 fourth-quarter revenues decrease 19%

Kun Run Biotechnology, Inc., a leading bio-pharmaceutical company in China that focuses on manufacturing and sales of peptides and peptide-based drugs, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2009.

30 Mar 2010

Irvine Scientific's Vit Kit- Freeze, Vit Kit- Thaw and Oil for Embryo Culture receive CE mark approval

Irvine Scientific, a leader in Assisted Reproductive Technology (ART), announced today it received CE mark approval for its Vit Kit®- Freeze, Vit Kit®- Thaw and Oil for Embryo Culture. This news accompanies the recent announcement of CE mark approval for a number of other media for ART from Irvine Scientific.

30 Mar 2010

BIOCIUS Life Sciences executes lease agreement for new Corporate Headquarters in Wakefield, MA

BIOCIUS Life Sciences Inc., developers of the RapidFire® high-throughput mass spectrometry system, today announced execution of a lease agreement for a new Corporate Headquarters in Wakefield, MA. The new facility located at 11 Audubon Road doubles the company's capacity and is a result of the increase in demand for RapidFire products and services.

30 Mar 2010

Silence Therapeutics, Dainippon Sumitomo Pharma announce expansion of siRNA delivery collaboration

Silence Therapeutics plc today announced that the company and Dainippon Sumitomo Pharma Co., Ltd. have agreed to an expansion of their ongoing small interfering RNA (siRNA) delivery collaboration. Under this collaboration, which was originally entered into in August 2009, the companies are leveraging Silence's proprietary siRNA molecules and multiple lipid delivery and targeting technologies to demonstrate functional delivery of RNA interference (RNAi) therapeutics to specific disease targets in the body.

30 Mar 2010

Manufacturing News and Research

Further Reading

Radiology benefit management programs can protect patients from radiation exposure

PolyMedix secures $14M credit facility with Hercules Technology II

Biostar Pharmaceuticals fiscal 2009 revenues up 57.2%

Soligenix's revenues for 2009 increase by 22%

Tanda Professional Restore light therapy now made available for at-home use

Cord Blood America signs License and Cooperation Agreement with AXM Pharma in China

IVAX Diagnostics reports net revenue of $4.5M for quarter ended December 31, 2009

2010 BIO International Convention to discuss issues that impact drug discovery and development

Tongjitang Chinese Medicines' net revenue rises 31.5% in fourth quarter 2009

Sanofi Pasteur accelerates deployment of Intercim's Pertinence Suite MOM software solution

AgaMatrix, sanofi-aventis announce long-term partnership for BGM solutions

Ikaria Holdings acquires NDA and IND application for LUCASSIN drug

Hospira acquires Orchid's injectables formulations business

Savient Pharmaceuticals' resubmission of BLA for KRYSTEXXA accepted for FDA review

Campbell Soup honored for commitment to food allergy safety, awareness and education

Investment report on Fonar from InvestorSoup.com

Kun Run Biotechnology's fiscal 2009 fourth-quarter revenues decrease 19%

Irvine Scientific's Vit Kit- Freeze, Vit Kit- Thaw and Oil for Embryo Culture receive CE mark approval

BIOCIUS Life Sciences executes lease agreement for new Corporate Headquarters in Wakefield, MA

Silence Therapeutics, Dainippon Sumitomo Pharma announce expansion of siRNA delivery collaboration

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News